Fulvestrant Sandoz 250 mg otopina za injekciju u napunjenoj štrcaljki
| Name | Fulvestrant Sandoz 250 mg otopina za injekciju u napunjenoj štrcaljki |
|---|---|
| Marketing Authorisation Number | HR-H-922713491 |
| Active Substance | fulvestrant |
| Composition | jedna napunjena štrcaljka sadrži 250 mg fulvestranta u 5 ml otopine |
| Pharmaceutical Form | otopina za injekciju u napunjenoj štrcaljki |
| Manufacturer | Lek Pharmaceuticals d.d., Ljubljana, Slovenija Ebewe Pharma GmbH Nfg. KG, Unterach am Attersee, Austrija Fareva Unterach GmbH, Unterach, Austrija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 07.07.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/223 |
| Registration Number | 381-12-01/70-20-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L02BA03 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
